Our findings highlight that IL-1β, IL-6, and RIPK3 play pivotal roles in these disease processes, with significantly elevated expression levels observed in the skin of SJS/TEN patients compared to those with lichen planus (LP) or normal controls. The gene discussed is IL1B; the disease is toxic epidermal necrolysis.